Dec 19, 2023 Cellectar Biosciences Expands Iopofosine I 131 Collaboration with Wisconsin Alumni Research Foundation Learn More
Dec 12, 2023 Cellectar Biosciences Strengthens Intellectual Property Protection for its PDC Platform Learn More
Dec 5, 2023 Cellectar Biosciences to Present at the Targeted Radiopharmaceuticals Summit Europe Learn More
Nov 2, 2023 Cellectar to Release Top-line Data from WM Pivotal Trial During the JP Morgan Healthcare Conference the Week of January 8, 2024 Learn More